Skip to main content

Galectin Therapeutics Inc (NASDAQ: GALT) Investor Securities Class Action Lawsuit 07/30/2014

  • If you purchased shares Galectin Therapeutics Inc (NASDAQ: GALT), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

December 30, 2015 - The court dismissed the case. June 26, 2015 - A motion to dismiss the consolidated complaint was filed. May 8, 2015 - A consolidated complaint was filed. January 21, 2015 - The case was transferred to the U.S. District Court for the Northern District of Georgia. July 30, 2014 - An investor in shares of of Galectin Therapeutics Inc (NASDAQ: GALT) filed a lawsuit in ...



You must register (for free) or login to view the entire case.